DRG accuracy: Don’t let payers decide what you’re owed
A CFO’s guide to pre-bill checks that hold up under audit
November 17, 2026
Blog
8 minutes
TL;DR
- Payers now test high-value DRGs against their own clinical criteria, so accuracy has to be settled before the claim drops.
- Software is strongest at ranking risky charts, while coders, CDI specialists, and physician advisors still make the final call.
- Measure DRG accuracy in dollars that survive payer review, reporting it next to compliance risk every month.
Why pre-bill accuracy matters | Why Pre-Bill Accuracy Matters
Who decides what a claim is worth: your coders before billing, or the payer’s auditors after payment? Any diagnosis-related group (DRG) left unchecked at discharge puts the final reimbursement decision into the payer’s hands. Just one major complication or comorbidity (MCC) removed on review can turn a higher-paying DRG into a lower-paying one.
Winning the difference back is expensive. According to the American Hospital Association, hospitals spent nearly $18 billion overturning denied claims in 2025. The window to improve DRG accuracy and keep the decision in-house is short: the days between discharge and claim submission.
Leading hospitals already act inside this window. They set the DRG themselves, back it with evidence built for audit, and leave payers little to reopen.
Payer audits set the DRG when hospitals don’t set it first | Payers Now Set the DRG
Benchmarking data from 2,300 hospitals show why the denial rate gives finance teams false comfort. While initial denials fell to 10.63% in the first half of 2026, down from 12% a year earlier, near-term cash didn’t follow.
The gap comes from payer activity after the first payment. Takebacks rose while provider recoveries dropped, which is the pattern a DRG downgrade follows. The payer pays the claim, then reviews the record and takes back revenue the hospital had already counted as earned. A hospital without a pre-bill defense ends up arguing its DRG in an appeal queue on the payer's timeline.
Coding downgrades and clinical validation denials need different defenses
Before responding to a DRG denial, hospitals need to know whether the payer is questioning the code or the diagnosis.
A coding downgrade questions whether the coder assigned and sequenced a code correctly under ICD-10-CM guidelines. Coders can usually answer this challenge from the record itself. On the other hand, a clinical validation denial accepts the code while disputing the diagnosis, often by applying the payer's own clinical criteria. Physicians may document to one clinical definition while the payer reviews against a stricter one. Winning this dispute takes a physician advisor plus a record showing the clinical evidence behind the diagnosis.
Every DRG fixed after billing costs more than one fixed before it | The Cost of Late Fixes
Post-payment fixes raise cost to collect on revenue the hospital already earned. Appeal writers, coders pulled off production, and physician advisors pulled from patient care add expensive rework to the same claim. Case mix reports rarely capture this spend.
Write-offs make the case for earlier review. Final denial write-offs fell to 3.07% of net revenue in the first half of 2026, from 3.31% a year earlier. Initial denials dropped by more than a full point over the same period.
The chart shows a gap finance teams can’t afford to miss: fewer denials haven't produced a comparable improvement in net revenue retained. For a hospital with $500 million in net revenue, a 3.07% write-off rate still means more than $15 million earned and never collected.
The cheapest place to shrink this number is before the claim drops. A query answered while the physician still remembers the patient takes minutes, but the same question raised by a payer months later means pulling records and writing an appeal. First-Pass Performance means getting the DRG right the first time, before the claim becomes expensive rework.
Pre-bill DRG checks can protect cash without slowing the bill | Pre-Bill Checks That Protect Cash
Moving review ahead of billing carries its own cash risk if teams try to read every chart. Discharged-not-final-billed days climb, trading one cash problem for another. Targeting avoids this trade: software ranks the risk, leaving people to spend their time on the cases that move money.
Which charts deserve a second look
Not every claim needs the same level of scrutiny before billing. Start where a coding change carries the greatest financial exposure:
- DRGs dependent on a single CC or MCC: One code removed on review can lower the DRG and reimbursement.
- Short stays with high-severity DRGs: A high-acuity classification paired with a short stay often warrants an extra documentation check.
- DRGs with repeat payer downgrades: Your own denial history shows where revenue is most likely to come back under review.
- High-dollar claims: The larger the reimbursement at stake, the greater the financial value of catching a DRG issue before billing.
Point scarce reviewer time at the dollars most likely to come back. A DRG that rests on a single CC or MCC and has been downgraded by a payer before carries the most exposure, so those cases get reviewed first. Cases that only show one signal stay in routine coding QA.
DRG analytics sharpen these priorities using your own payer outcomes, showing which high-risk claims carry the most revenue exposure. A coding audit and quality assurance program then tracks whether the same DRG issues keep coming back.
Where analytics points and people decide
Once the targets are set, technology does the initial reading. AI-enabled coding tools score every chart for risk, flagging thin support such as a diagnosis with no matching labs or treatment. AI-powered execution technology then routes the right chart to the right reviewer before the bill drops. When products promise DRG optimization with AI, the better test is whether the tool explains why it flagged each case.
The tool’s job ends at the flag, when it brings the right cases forward to a human for review. From there, a clinical documentation integrity specialist determines whether the record warrants a query. The physician provides the clinical answer, building the documentation needed to support the DRG through payer review.
AI coding audits can also run in the other direction. Pointed at your own coded output, they find undercoding, where documented severity never reached the claim. This leak draws less attention than a payer downgrade while costing just as much.
The flag-and-decide model for DRG accuracy
DRG accuracy and compliance belong on the same finance dashboard | One Finance Dashboard for DRGs
Charts reviewed and queries sent show effort, but finance needs to see results. The most useful measures are the share of high-risk DRGs that survive payer review, the dollars protected before billing, and the dollars lost to downgrades.
Analytics focus review on the claims with the greatest exposure. Coders and clinical reviewers determine what the documentation supports. Getting the DRG right the first time reduces the amount of earned revenue that comes back into question after payment. Open Accountability keeps those results visible, connecting DRG accuracy to the dollars protected, lost and ultimately collected.
The result is less rework for coding and clinical teams and a steadier path from billed revenue to cash.
Get a pre-bill DRG risk review for your top payers
Share a sample of recent inpatient claims. We'll show where downgrades start and where reviewer time protects the most cash.
Continue exploring expert perspectives, industry trends, and practical strategies for improving revenue cycle performance.
Explore Points Of ViewFrequently Asked Questions
How can a hospital improve DRG accuracy before claims are billed?

Rank inpatient charts by financial risk rather than reviewing every discharged account in the order it arrived. Send high-risk cases, such as single-MCC DRGs and short high-severity stays, to coders and CDI specialists first. Then track how many reviewed DRGs survive payer review unchanged, adjusting the risk rules every quarter.
What is the difference between a DRG downgrade and a clinical validation denial?

A coding downgrade challenges whether codes were assigned and sequenced correctly under official ICD-10-CM coding guidelines. A clinical validation denial accepts the code but argues the medical record fails to support the diagnosis. Coders usually answer coding downgrades, while clinical validation denials need a physician advisor and strong clinical evidence.
Can AI decide the final DRG on an inpatient claim?

AI can score downgrade risk on every chart and flag diagnoses lacking supporting labs or treatment. Queries and clinical judgments stay with CDI specialists and physicians, which means software can't settle the DRG alone. The safest design lets software point to risky cases and requires a named person to approve release. Ask any partner to show why the tool flagged each case, letting reviewers audit the logic behind it.
How should a CFO measure DRG accuracy and compliance?

Measure the share of high-risk DRGs that survive payer review unchanged, rather than counting charts your team reviewed. Add net dollars protected before billing, downgrade losses by payer and diagnosis, plus the cost of each recovery. Report overcoding corrections beside undercoding gains, so auditors can see the program corrects errors in both directions.
What is undercoding, and how do AI coding audits find it?

Undercoding happens when documented conditions or procedures never reach the claim, so the hospital bills a lower DRG. AI coding audits compare the full record against coded output and flag severity that went uncaptured on claims. A coding auditor then confirms each finding, because some flagged conditions lack the documentation needed to code them.
